Article thumbnail
Location of Repository

Behaviour Management Problems as Predictors of Psychotropic Medication and Use of Psychiatric Services in Adults with Autism

By Elias Tsakanikos


We examined behaviour management problems as predictors of psychotropic medication, use of psychiatric consultation and in-patient admission in a group of 66 adults with pervasive developmental disorder (PDD) and intellectual disability (ID) and 99 controls matched in age, gender and level of ID. Overall, people with PDD had higher rates of most DAS behaviour problems and more frequent use of anti-psychotics than matched controls. Logistic regression analyses showed that physical aggression and problems such as pestering staff independently predicted use of anti-psychotics. Physical aggression and overactivity predicted further involvement of \ud psychiatric services. PDD diagnosis predicted admission to an in-patient unit. The results suggest that externalizing problem behaviours in adults with autism can predict type of treatment intervention. \ud \ud \ud \u

Topics: Clinical Psychology
Year: 2007
OAI identifier:

Suggested articles


  1. (2005). Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood.
  2. (2002). Crisis prevention and response in the community.
  3. (2003). Epidemiological surveys of autism and other pervasive developmental disorders: an update.
  4. (2005). Evidence-based practices in intellectual disability and behaviour disorders.
  5. (1999). Meta-analytic study on treatment effectiveness for problem behaviors with individuals who have mental retardation.
  6. (2003). Outcome in high-functioning adults with autism with and without early language delays: implications for the differentiation between autism and Asperger syndrome. doi
  7. (1999). Positive behaviour support in people with developmental disabilities: a research synthesis (Monograph (American Association on Mental Retardation).
  8. (1999). Psychiatric and behavioural disorders in developmental disabilities and mental retardation. Cambridge:
  9. (2003). Psychopharmacology in autism spectrum disorders. doi
  10. (1995). Psychotropic drug use in group homes: prevalence and relation to demographic / psychiatric variables.
  11. (2003). Risk markers associated with challenging behaviours in people with intellectual disabilities: a meta-analytic study. doi
  12. (2005). Systematic review of randomized controlled trials of atypical antipsychotics and selective serotonin reuptake inhibitors for behavioural problems associated with pervasive developmental disorders.
  13. (1999). The epidemiology of autism: a review.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.